{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:05:54Z","timestamp":1785420354824,"version":"3.56.0"},"reference-count":7,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Experiments on mice suggest that an approach called antisense oligonucleotide therapy may be able to treat some symptoms of Angelman syndrome, including problems with epilepsy and sleep.<\/jats:p>","DOI":"10.7554\/elife.86117","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T10:15:13Z","timestamp":1675419313000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.86117","source":"Crossref","is-referenced-by-count":2,"title":["How late is too late for treatment?"],"prefix":"10.7554","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-2630","authenticated-orcid":true,"given":"Lawrence T","family":"Reiter","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0011qv509","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Neurology, Department of Pediatrics, Department of Anatomy and Neurobiology, College of Medicine, University of Tennessee Health Science Center","place":["Memphis, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"bib1","article-title":"Angelman syndrome","volume-title":"GeneReviews","author":"Dagli","year":"1993","unstructured":"Dagli AI, Mathews J, Williams CA. 1993. Angelman syndrome. GeneReviews. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1144\/ [Accessed February 2, 2023]."},{"key":"bib2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000517686","article-title":"Antisense oligonucleotide therapy for neurodevelopmental disorders","volume":"43","author":"Hill","year":"2021","journal-title":"Developmental Neuroscience"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0197-70","article-title":"UBE3A\/E6-AP mutations cause Angelman syndrome","volume":"15","author":"Kishino","year":"1997","journal-title":"Nature Genetics"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81892","article-title":"Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome","volume":"12","author":"Lee","year":"2023","journal-title":"eLife"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ng0197-74","article-title":"De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome","volume":"15","author":"Matsuura","year":"1997","journal-title":"Nature Genetics"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0231-7","article-title":"A behavioral test battery for mouse models of Angelman syndrome: A powerful tool for testing drugs and novel Ube3a mutants","volume":"9","author":"Sonzogni","year":"2018","journal-title":"Molecular Autism"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1101\/gr.7.4.368","article-title":"The E6-AP ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region","volume":"7","author":"Sutcliffe","year":"1997","journal-title":"Genome Research"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/86117\/elife-86117-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/86117\/elife-86117-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/86117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T21:15:14Z","timestamp":1697058914000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/86117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":7,"alternative-id":["10.7554\/eLife.86117"],"URL":"https:\/\/doi.org\/10.7554\/elife.86117","archive":["CLOCKSS"],"relation":{},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"article-number":"e86117"}}